These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31490238)

  • 1. Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas.
    Lobo J; Stoop H; Gillis AJM; Looijenga LHJ; Oosterhuis W
    Am J Surg Pathol; 2019 Dec; 43(12):1711-1719. PubMed ID: 31490238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers.
    Lobo J; Gillis AJM; van den Berg A; Looijenga LHJ
    BMC Cancer; 2020 Aug; 20(1):728. PubMed ID: 32758242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of intravascular granulomas in testicular seminomas and their association with tumour relapse and dissemination.
    Downes MR; Cheung CC; Pintilie M; Chung P; van der Kwast TH
    J Clin Pathol; 2016 Jan; 69(1):47-52. PubMed ID: 26193899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study investigating the detection of lymphovascular invasion in germ cell tumors of the testis with double staining for OCT4/CD34.
    Ricci C; Franceschini T; Giunchi F; Borsato M; Mollica V; Massari F; Fiorentino M
    Pathol Res Pract; 2021 Nov; 227():153637. PubMed ID: 34619577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists.
    Lobo J; Costa AL; Vilela-Salgueiro B; Rodrigues Â; Guimarães R; Cantante M; Lopes P; Antunes L; Jerónimo C; Henrique R
    Hum Pathol; 2018 Dec; 82():113-124. PubMed ID: 30041024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular invasion of testicular nonseminomatous germ cell tumors: implications of separate evaluation of lymphatic and blood vessels.
    Heinzelbecker J; Gross-Weege M; Weiss C; Hörner C; Trunk MJ; Erben P; Haecker A; Bolenz C
    J Urol; 2014 Aug; 192(2):593-9. PubMed ID: 24631105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Significance of Spermatic Cord Involvement by Testicular Germ Cell Tumors: Should We Be Staging Discontinuous Invasion From Involved Lymphovascular Spaces Differently From Direct Extension?
    Sanfrancesco JM; Trevino KE; Xu H; Ulbright TM; Idrees MT
    Am J Surg Pathol; 2018 Mar; 42(3):306-311. PubMed ID: 29309304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion in colorectal cancer: an interobserver variability study.
    Harris EI; Lewin DN; Wang HL; Lauwers GY; Srivastava A; Shyr Y; Shakhtour B; Revetta F; Washington MK
    Am J Surg Pathol; 2008 Dec; 32(12):1816-21. PubMed ID: 18779725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
    Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
    J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
    Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
    World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell invasion in blood vessels assessed by immunohistochemistry is related to decreased survival in patients with bladder cancer treated with radical cystectomy.
    Carlsen B; Klingen TA; Andreassen BK; Haug ES
    Diagn Pathol; 2021 Nov; 16(1):109. PubMed ID: 34809660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?
    Scandura G; Wagner T; Beltran L; Alifrangis C; Shamash J; Berney DM
    Mod Pathol; 2021 Apr; 34(4):834-841. PubMed ID: 33319858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
    Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
    J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study.
    Sesterhenn IA; Weiss RB; Mostofi FK; Stablein DM; Rowland RG; Falkson G; Rivkind SE; Vogelzang NJ
    J Clin Oncol; 1992 Jan; 10(1):69-78. PubMed ID: 1309382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
    Cohn-Cedermark G; Stahl O; Tandstad T;
    Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial.
    Pont J; Höltl W; Kosak D; Machacek E; Kienzer H; Julcher H; Honetz N
    J Clin Oncol; 1990 Jan; 8(1):16-20. PubMed ID: 1688613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.
    Storr SJ; Safuan S; Mitra A; Elliott F; Walker C; Vasko MJ; Ho B; Cook M; Mohammed RA; Patel PM; Ellis IO; Newton-Bishop JA; Martin SG
    Mod Pathol; 2012 Apr; 25(4):493-504. PubMed ID: 22080065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.